https://onco-hema.healthbooktimes.org/ daily https://onco-hema.healthbooktimes.org/for-authors monthly https://onco-hema.healthbooktimes.org/editorial-board monthly https://onco-hema.healthbooktimes.org/pages/271-publishing-policies 2025-08-07 https://onco-hema.healthbooktimes.org/pages/272-open-access 2022-06-28 https://onco-hema.healthbooktimes.org/articles monthly https://onco-hema.healthbooktimes.org/issues monthly https://onco-hema.healthbooktimes.org/article/27177-urothelial-carcinoma-highlights-from-asco-gu-2021-ground-breaking-studies 2025-05-27 https://onco-hema.healthbooktimes.org/article/55660-maximizing-the-benefit-of-car-t-cell-therapy-in-lymphoma-and-multiple-myeloma 2025-05-27 https://onco-hema.healthbooktimes.org/article/158213-the-emerging-role-of-oral-serds-in-early-breast-cancer 2026-03-09 https://onco-hema.healthbooktimes.org/article/127721-pirtobrutinib-for-the-treatment-of-b-cell-malignancies-recent-developments 2025-06-16 https://onco-hema.healthbooktimes.org/article/116054-recent-advances-in-cervical-cancer-treatment 2025-05-27 https://onco-hema.healthbooktimes.org/article/158216-bridge-the-gap-to-car-bridging-therapy-in-car-t-cell-therapy-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma 2026-03-09 https://onco-hema.healthbooktimes.org/article/38274-promising-findings-in-myeloproliferative-neoplasms-and-al-amyloidosis 2025-05-27 https://onco-hema.healthbooktimes.org/article/29129-urothelial-carcinoma-optimal-treatment-options-in-first-line-and-beyond 2025-05-27 https://onco-hema.healthbooktimes.org/article/141834-fourth-swiss-annual-meeting-on-her2-positive-breast-cancer-antibody-drug-conjugates-in-her2-positive-disease-and-beyond 2025-08-29 https://onco-hema.healthbooktimes.org/article/158662-hormone-replacement-therapy-after-endometrial-cancer-current-evidence-and-treatment-recommendations 2026-03-12 https://onco-hema.healthbooktimes.org/article/158658-high-dose-chemotherapy-and-stem-cell-transplantation-in-zbtb16-rara-acute-promyelocytic-leukemia-a-case-report 2026-03-11 https://onco-hema.healthbooktimes.org/article/36893-highlights-in-renal-cell-carcinoma-from-asco-gu-2022 2025-05-27 https://onco-hema.healthbooktimes.org/article/55661-eortc-cltg-2022-vital-platform-to-discuss-the-recent-advances-in-cutaneous-lymphomas 2025-05-27 https://onco-hema.healthbooktimes.org/article/29139-esmo-congress-2021-news-update-systemic-therapy-in-early-and-advanced-breast-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/82223-artificial-intelligence-in-cancer-medicine-the-future-of-cancer-care 2025-05-27 https://onco-hema.healthbooktimes.org/article/91254-current-challenges-in-treating-unresectable-hepatocellular-carcinoma 2025-05-27 https://onco-hema.healthbooktimes.org/article/90131-recent-progress-in-thoracic-oncology-wclc-2023-highlights 2025-05-27 https://onco-hema.healthbooktimes.org/article/24422-critical-review-of-egfr-mutated-nsclc-what-we-do-and-do-not-know 2025-05-27 https://onco-hema.healthbooktimes.org/article/24424-precision-oncology-in-gastro-esophageal-adenocarcinoma 2025-05-27 https://onco-hema.healthbooktimes.org/article/83226-asco-2023-targeted-therapy-for-early-stage-nsclc 2025-05-27 https://onco-hema.healthbooktimes.org/article/83229-harnessing-the-power-of-existing-therapeutic-strategies-to-treat-cutaneous-t-cell-lymphomas 2025-05-27 https://onco-hema.healthbooktimes.org/article/125802-personalized-organoid-based-treatments-in-older-patients-with-cancer-a-registry-study-in-progress 2025-08-05 https://onco-hema.healthbooktimes.org/article/141832-current-advances-in-the-perioperative-treatment-of-muscle-invasive-bladder-cancer 2025-07-11 https://onco-hema.healthbooktimes.org/article/55669-precision-oncology-another-tower-of-babel 2025-05-27 https://onco-hema.healthbooktimes.org/article/145936-psma-radioligands-for-diagnostics-and-treatment-of-advanced-prostate-cancer 2025-12-18 https://onco-hema.healthbooktimes.org/article/36895-geriatric-oncology-building-clinical-care-for-swiss-patients 2025-05-27 https://onco-hema.healthbooktimes.org/article/30724-highlights-in-prostate-cancer-from-esmo-2021 2025-05-27 https://onco-hema.healthbooktimes.org/article/29141-highlights-in-car-t-cell-therapy-from-eha2021-paving-the-way-for-better-treatments 2025-05-27 https://onco-hema.healthbooktimes.org/article/27179-the-car-t-cell-story 2025-05-27 https://onco-hema.healthbooktimes.org/article/27178-renal-cell-carcinoma-highlights-from-asco-gu-2021-key-updates 2025-05-27 https://onco-hema.healthbooktimes.org/article/67972-training-the-next-generation-of-physicians-recognizing-the-importance-of-women-in-leadership-roles 2025-05-27 https://onco-hema.healthbooktimes.org/article/136354-bridging-the-knowledge-gaps-in-cancer-medicine-a-call-for-precision-equity-and-real-world-evidence 2025-05-27 https://onco-hema.healthbooktimes.org/article/154490-car-t-cell-therapy-for-richter-s-syndrome-and-central-nervous-system-ptld-after-solid-organ-transplantation-two-case-reports 2026-01-05 https://onco-hema.healthbooktimes.org/article/33626-the-evolving-treatment-landscape-of-aml 2025-05-27 https://onco-hema.healthbooktimes.org/article/24833-breast-cancer-treatment-in-the-era-of-precision-medicine 2025-05-27 https://onco-hema.healthbooktimes.org/article/24829-targeting-the-tumor-in-colorectal-cancer-where-do-we-stand-with-precision-medicine-in-2020 2025-05-27 https://onco-hema.healthbooktimes.org/article/116036-recent-progress-in-breast-cancer-treatment 2025-05-27 https://onco-hema.healthbooktimes.org/article/25651-systemic-al-amyloidosis-and-precision-medicine 2025-05-27 https://onco-hema.healthbooktimes.org/article/91243-psma-directed-radioligand-therapy-for-metastatic-prostate-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/90138-the-gaining-momentum-of-bcma-directed-therapies-for-relapsed-refractory-multiple-myeloma 2025-05-27 https://onco-hema.healthbooktimes.org/article/116188-recent-developments-in-treatment-of-older-patients-with-breast-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/90106-antibody-drug-conjugates-in-ovarian-cancer-promises-and-challenges 2025-05-27 https://onco-hema.healthbooktimes.org/article/116250-rare-adverse-events-of-car-t-cell-therapy 2025-05-27 https://onco-hema.healthbooktimes.org/article/116473-myelodysplastic-neoplasms-the-impact-of-clonality-on-inflammatory-degenerative-diseases-of-the-elderly 2025-05-27 https://onco-hema.healthbooktimes.org/article/24761-precision-oncology-and-gender-medicine-moving-forward-slowly-but-surely 2025-05-27 https://onco-hema.healthbooktimes.org/article/25637-multidisciplinary-approach-to-a-patient-with-acinar-cell-carcinoma-a-rare-pancreatic-malignancy 2025-05-27 https://onco-hema.healthbooktimes.org/article/24407-first-line-treatment-of-_alk_-positive-nsclc 2025-05-27 https://onco-hema.healthbooktimes.org/article/36897-treatment-options-for-non-small-cell-lung-cancer-harboring-uncommon-egfr-mutations 2025-05-27 https://onco-hema.healthbooktimes.org/article/29070-the-rapidly-changing-treatment-landscape-of-systemic-therapy-for-her-2-positive-metastatic-breast-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/24420-response-to-osimertinib-in-a-patient-with-non-small-cell-lung-cancer-and-two-uncommon-egfr-mutations 2025-05-27 https://onco-hema.healthbooktimes.org/article/24401-immunotherapy-in-advanced-gastroesophageal-tumors-the-best-of-the-current-knowledge 2025-05-27 https://onco-hema.healthbooktimes.org/article/24421-a-rational-sequencing-of-anti-angiogenic-agents-as-second-line-treatment-choice-for-mcrc-patients-progressing-after-a-bevacizumab-based-first-line 2025-05-27 https://onco-hema.healthbooktimes.org/article/25627-current-standard-of-care-in-patients-with-myelodysplastic-syndromes-and-future-perspectives 2025-05-27 https://onco-hema.healthbooktimes.org/article/25694-esmo-updates-the-guidelines-for-the-diagnosis-of-ret-altered-cancer-to-herald-a-new-era-in-targeted-therapy 2025-05-27 https://onco-hema.healthbooktimes.org/article/91247-swiss-amyloidosis-network-san-objectives-and-challenges 2025-05-27 https://onco-hema.healthbooktimes.org/article/25928-mycosis-fungoides-and-sezary-syndrome 2025-05-27 https://onco-hema.healthbooktimes.org/article/29158-overcoming-parp-inhibitor-and-platinum-resistance-with-wee1-inhibitors-in-ovarian-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/25636-artificial-intelligence-clinical-application-in-prostate-cancer-molecular-imaging 2025-05-27 https://onco-hema.healthbooktimes.org/article/25715-use-of-diagnostic-algorithms-for-ntrk-fusion-positive-tumors-in-pathology-institutes-in-switzerland 2025-05-27 https://onco-hema.healthbooktimes.org/article/25898-avenues-to-precision-oncology 2025-05-27 https://onco-hema.healthbooktimes.org/article/24206-long-term-sustained-disease-control-with-immunotherapy-in-chemotherapy-refractory-merkel-cell-carcinoma 2025-05-27 https://onco-hema.healthbooktimes.org/article/24393-therapy-management-of-metastatic-prostate-carcinoma-in-general-practice 2025-05-27 https://onco-hema.healthbooktimes.org/article/92113-boosting-immunity-and-enhancing-wellbeing-the-transformative-impact-of-supportive-care-on-cancer-outcomes 2025-05-27 https://onco-hema.healthbooktimes.org/article/89275-routine-genetic-testing-of-germline-breast-cancer-susceptibility-challenges-and-opportunities 2025-06-16 https://onco-hema.healthbooktimes.org/article/94081-geriatric-assessment-of-older-patients-with-cancer-recent-data-and-updated-recommendations 2025-05-27 https://onco-hema.healthbooktimes.org/article/26106-use-of-first-line-parp-inhibitors-in-ovarian-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/26108-neither-last-nor-least-integration-of-early-palliative-care-into-standard-oncology-care 2025-05-27 https://onco-hema.healthbooktimes.org/article/25188-multiple-myeloma-with-a-special-focus-on-precision-medicine 2025-05-27 https://onco-hema.healthbooktimes.org/article/29050-clonal-hematopoiesis-of-indeterminate-potential-new-insights-from-recent-studies 2025-05-27 https://onco-hema.healthbooktimes.org/article/77814-geriatric-oncology-novel-data-from-the-siog-2022-annual-conference 2025-05-27 https://onco-hema.healthbooktimes.org/article/38272-emerging-treatment-options-in-lung-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/90128-reninoma-a-case-of-a-small-renal-mass-removed-with-robotic-assisted-surgery 2025-05-27 https://onco-hema.healthbooktimes.org/article/33624-highlights-in-multiple-myeloma-from-ash-2021 2025-05-27 https://onco-hema.healthbooktimes.org/article/121109-caring-for-the-professional-caregivers-in-cancer-medicine-an-overlooked-necessity 2025-05-27 https://onco-hema.healthbooktimes.org/article/124358-antibody-drug-conjugates-in-the-treatment-of-metastatic-breast-cancer-the-emerging-questions-of-sequence-and-resistance 2025-05-27 https://onco-hema.healthbooktimes.org/article/25709-systemic-treatments-for-unresectable-pleural-mesothelioma-a-review-of-the-literature 2025-05-27 https://onco-hema.healthbooktimes.org/article/25647-the-microbiome-and-cancer-a-dangerous-liaison 2025-05-27 https://onco-hema.healthbooktimes.org/article/25696-swiss-recommendations-for-systemic-therapies-in-locally-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma 2025-05-27 https://onco-hema.healthbooktimes.org/article/24395-cd19-directed-car-t-cells-treatment-in-a-patient-with-refractory-dlbcl-and-cns-involvement 2025-05-27 https://onco-hema.healthbooktimes.org/article/33622-highlights-in-al-amyloidosis-from-ash-2021 2025-05-27 https://onco-hema.healthbooktimes.org/article/67978-advances-in-colon-cancer-therapy 2025-05-27 https://onco-hema.healthbooktimes.org/article/38271-exciting-progress-in-acute-myeloid-leukemia-management 2025-05-27 https://onco-hema.healthbooktimes.org/article/29045-management-of-cancer-during-the-covid-19-pandemic-the-rewritten-rules 2025-05-27 https://onco-hema.healthbooktimes.org/article/30740-highlights-in-non-prostate-genitourinary-tumors-at-esmo-2021-revolutionizing-management-options-for-better-therapy 2025-05-27 https://onco-hema.healthbooktimes.org/article/83228-recent-progress-in-immunotherapy-for-rrmm-updates-from-eha-2023-congress 2025-05-27 https://onco-hema.healthbooktimes.org/article/73782-long-term-response-to-pd-1-and-ctla-4-blockade-in-an-sclc-patient-with-negative-pd-l1-expression-on-biopsy-a-case-report 2025-05-27 https://onco-hema.healthbooktimes.org/article/55668-clinical-cancer-research-in-switzerland 2025-05-27 https://onco-hema.healthbooktimes.org/article/73778-supportive-care-treatment-in-cancer-patients 2025-05-27 https://onco-hema.healthbooktimes.org/article/25626-precision-medicine-in-bcr-abl1-negative-myeloproliferative-neoplasms 2025-05-27 https://onco-hema.healthbooktimes.org/article/73788-car-t-cell-therapy-paving-the-path-to-a-brighter-future-in-lbcl 2025-05-27 https://onco-hema.healthbooktimes.org/article/33623-highlights-in-car-t-cell-therapy-from-ash-2021-potential-practice-changing-treatments 2025-05-27 https://onco-hema.healthbooktimes.org/article/24805-molecular-diagnostic-and-precision-medicine-in-non-small-cell-lung-cancer-an-update-on-the-treatment-of-the-most-important-actionable-oncogenic-drive 2025-05-27 https://onco-hema.healthbooktimes.org/article/38277-exciting-new-data-in-newly-diagnosed-multiple-myeloma 2025-05-27 https://onco-hema.healthbooktimes.org/article/24752-precision-oncology-for-hepato-pancreato-biliary-hpb-cancers-state-of-the-art-and-future-directions 2025-05-27 https://onco-hema.healthbooktimes.org/article/90102-classification-of-cutaneous-lymphomas-an-update 2025-05-27 https://onco-hema.healthbooktimes.org/article/141449-a-landmark-year-for-lung-cancer-research-at-asco-2025 2025-07-07 https://onco-hema.healthbooktimes.org/article/73784-isavuconazole-breakthrough-disseminated-fusarium-fujikuroi-infection-in-a-patient-with-allogeneic-hematopoietic-stem-cell-transplant-diagnostic-and 2025-05-27 https://onco-hema.healthbooktimes.org/article/55670-long-term-outcomes-in-patients-with-plasma-cell-myeloma-following-high-dose-chemotherapy-with-autologous-stem-cell-transplantation 2025-06-16 https://onco-hema.healthbooktimes.org/article/158218-parp-inhibition-as-an-effective-therapeutic-strategy-in-disseminated-tnbc-with-extensive-cns-metastases-a-case-report 2026-03-23 https://onco-hema.healthbooktimes.org/article/30741-highlights-in-gynecological-cancer-from-esmo-2021 2025-05-27 https://onco-hema.healthbooktimes.org/article/29137-cll-and-lymphoma-studies-at-eha2021-and-16-icml 2025-05-27 https://onco-hema.healthbooktimes.org/article/29135-highlights-in-multiple-myeloma-treatment-from-eha2021 2025-05-27 https://onco-hema.healthbooktimes.org/article/90098-navigating-through-the-dynamic-world-of-hematology-and-oncology 2025-05-27 https://onco-hema.healthbooktimes.org/article/25190-hodgkin-s-lymphoma-after-autologous-stem-cell-transplantation-effective-consolidation-with-brentuximab-vedotin 2025-05-27 https://onco-hema.healthbooktimes.org/article/25932-metastatic-pancreatic-cancer-current-treatment-options-for-swiss-patients 2025-05-27 https://onco-hema.healthbooktimes.org/article/25692-targeted-therapy-in-ovarian-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/73748-extinguishing-the-fire-of-inflammation-in-clonal-hematopoiesis 2025-05-27 https://onco-hema.healthbooktimes.org/article/82225-the-changing-landscape-of-urothelial-carcinoma-therapy-updates-from-asco-gu-2023 2025-05-27 https://onco-hema.healthbooktimes.org/article/33625-2021-update-on-systemic-therapy-for-breast-cancer 2025-06-16 https://onco-hema.healthbooktimes.org/article/158220-antibody-drug-conjugate-sequencing-in-metastatic-breast-cancer 2026-03-12 https://onco-hema.healthbooktimes.org/article/90105-unlocking-the-potential-of-antibody-drug-conjugates-in-cancer-medicine-efficacy-and-side-effects 2025-05-27 https://onco-hema.healthbooktimes.org/article/25192-genomic-testing-for-advanced-prostate-cancer-ready-for-prime-time 2025-05-27 https://onco-hema.healthbooktimes.org/article/27176-prostate-cancer-highlights-from-asco-gu-2021-cutting-edge-results 2025-05-27 https://onco-hema.healthbooktimes.org/article/36891-highlights-in-prostate-cancer-from-asco-gu-2022 2025-05-27 https://onco-hema.healthbooktimes.org/article/128486-a-bright-future-for-immunotherapy-car-t-cell-therapy-promises-revolutionary-changes 2025-06-16 https://onco-hema.healthbooktimes.org/article/121117-readiness-for-innovation-and-pioneer-spirit 2025-05-27 https://onco-hema.healthbooktimes.org/article/92382-surgical-therapy-of-localized-prostate-cancer-update-on-treatment-approaches-and-education-challenges 2025-05-27 https://onco-hema.healthbooktimes.org/article/24827-folate-receptor-a-new-target-for-an-old-enemy 2025-05-27 https://onco-hema.healthbooktimes.org/article/24423-oncofertility-approach-in-females-with-leukemia-from-the-reproductive-perspective 2025-05-27 https://onco-hema.healthbooktimes.org/article/124360-organoid-technology-in-oncology-a-new-frontier-for-personalized-treatment 2025-05-27 https://onco-hema.healthbooktimes.org/article/33919-benefits-and-complications-following-first-line-treatment-with-atezolizumab-plus-bevacizumab-in-a-patient-with-hcc-a-case-report 2025-05-27 https://onco-hema.healthbooktimes.org/article/29047-mrna-vaccines-against-infectious-diseases-and-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/141451-beyond-her2-positive-the-adc-revolution-in-breast-cancer-care 2025-07-07 https://onco-hema.healthbooktimes.org/article/141454-in-response-to-caring-for-the-professional-caregivers-in-cancer-medicine-an-overlooked-necessity-by-marcus-vetter 2025-07-07 https://onco-hema.healthbooktimes.org/article/33628-antibody-drug-conjugates-in-solid-tumors 2025-06-16 https://onco-hema.healthbooktimes.org/article/33627-from-new-molecular-insights-to-new-treatment-options-in-endometrial-cancer 2025-06-16 https://onco-hema.healthbooktimes.org/article/30710-management-of-elderly-and-old-cancer-patients-geriatric-oncology 2025-06-16 https://onco-hema.healthbooktimes.org/article/120927-ebmt-eha-6th-european-car-t-cell-meeting-2024-advancing-treatments-and-new-frontiers 2025-05-27 https://onco-hema.healthbooktimes.org/article/116144-what-is-the-optimal-treatment-duration-of-immunotherapy-for-nsclc 2025-06-16 https://onco-hema.healthbooktimes.org/article/67979-expanding-treatment-options-in-muc-and-mrcc 2025-05-27 https://onco-hema.healthbooktimes.org/article/89334-updates-on-radiotherapy-for-localized-prostate-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/68151-emberger-syndrome-a-family-history-over-3-generations 2025-05-27 https://onco-hema.healthbooktimes.org/article/82122-recurrent-cutaneous-fusariosis-in-a-kidney-transplant-recipient-a-case-report-and-review-of-the-literature 2025-05-27 https://onco-hema.healthbooktimes.org/article/82123-benefits-and-applications-of-oncotype-dx-breast-recurrence-score-testing-among-breast-cancer-patients-current-recommendations-and-controversies 2025-06-16 https://onco-hema.healthbooktimes.org/article/145880-lung-cancer-research-from-the-swiss-cancer-institute-elcc-2025-highlights 2025-12-18 https://onco-hema.healthbooktimes.org/article/116252-endometrial-cancer-updates-in-molecular-characterization-and-treatment-opportunities 2025-06-16 https://onco-hema.healthbooktimes.org/article/124356-navigating-the-evolving-treatment-paradigm-for-_egfr_-mutant-nsclc 2025-05-27 https://onco-hema.healthbooktimes.org/article/73780-updates-in-cutaneous-t-cell-lymphomas-at-ash-2022 2025-05-27 https://onco-hema.healthbooktimes.org/article/67985-updates-on-therapy-for-gynecologic-cancers 2025-05-27 https://onco-hema.healthbooktimes.org/article/67981-the-power-of-precision-why-precision-medicine-is-the-future-of-cancer-treatment-and-how-it-implies-in-elderly-cancer-patients 2025-05-27 https://onco-hema.healthbooktimes.org/article/120879-rare-toxicities-of-car-t-cell-therapy-cardiovascular-hematopoietic-and-other-infrequent-adverse-events 2025-05-27 https://onco-hema.healthbooktimes.org/article/120922-assessment-and-treatment-of-elderly-patients-with-multiple-myeloma 2025-06-16 https://onco-hema.healthbooktimes.org/article/55658-significant-progress-in-car-t-cell-therapy-for-difficult-to-treat-hematologic-malignancies 2025-05-27 https://onco-hema.healthbooktimes.org/article/120914-evolving-treatment-landscape-in-endometrial-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/83227-asco-2023-recent-progress-in-lung-cancer-therapy 2025-05-27 https://onco-hema.healthbooktimes.org/article/67977-optimized-colorectal-cancer-patients-management-during-the-covid-19-pandemic-triage-and-treatment 2025-06-16 https://onco-hema.healthbooktimes.org/article/67980-diagnostic-approach-clinical-implications-and-management-of-clonal-cytopenia-of-undetermined-significance 2025-05-27 https://onco-hema.healthbooktimes.org/article/154290-recent-advances-in-radioligand-therapy 2026-01-05 https://onco-hema.healthbooktimes.org/article/121113-antibody-drug-conjugates-in-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/121111-writing-history-in-the-adjuvant-treatment-of-clear-cell-renal-cell-carcinoma-ccrcc-the-magic-goal-of-an-overall-survival-benefit-was-reached-as-rep 2025-05-27 https://onco-hema.healthbooktimes.org/article/121120-adding-androgen-receptor-pathway-inhibition-with-enzalutamide-to-androgen-deprivation-therapy-in-prostate-cancer-patients-with-high-risk-biochemical-r 2025-05-27 https://onco-hema.healthbooktimes.org/article/121122-landmark-paloma-and-mariposa-studies-reveal-the-impact-of-amivantamab-alone-and-combined-with-lazertinib-in-advanced-nsclc 2025-05-27 https://onco-hema.healthbooktimes.org/article/124515-durvalumab-plus-chemotherapy-for-advanced-biliary-tract-cancer-treatment-insights-from-the-topaz-1-trial 2025-06-16 https://onco-hema.healthbooktimes.org/article/77812-the-san-antonio-breast-cancer-conference-2022-an-overview 2025-05-27 https://onco-hema.healthbooktimes.org/article/124198-third-swiss-annual-meeting-on-her2-positive-breast-cancer-recent-advances-and-new-challenges 2025-06-16 https://onco-hema.healthbooktimes.org/article/125800-advanced-melanoma-updated-results-from-ongoing-trials 2025-06-16 https://onco-hema.healthbooktimes.org/article/141742-advances-in-the-treatment-of-higher-risk-mds-current-strategies-and-emerging-therapies 2025-07-08 https://onco-hema.healthbooktimes.org/article/141740-the-evolving-role-of-alkylating-agents-in-multiple-myeloma-from-the-past-and-present-to-next-generation-peptide-drug-conjugates 2025-07-15 https://onco-hema.healthbooktimes.org/article/141744-advances-in-prostate-cancer-insights-from-asco-gu-2025 2025-07-08 https://onco-hema.healthbooktimes.org/article/36896-research-for-tomorrow 2025-05-27 https://onco-hema.healthbooktimes.org/article/82126-integrating-geriatric-care-in-clinical-oncology-practice-recommendations-from-an-interdisciplinary-professional-survey-study-in-a-single-cancer-cente 2025-06-16 https://onco-hema.healthbooktimes.org/article/91249-advancing-ovarian-cancer-treatment-the-latest-insights-on-parp-inhibitors-from-asco-2023 2025-05-27 https://onco-hema.healthbooktimes.org/article/137800-what-does-the-future-hold-for-the-treatment-of-flt3-mutated-aml-news-and-insights-from-ash-2024 2025-05-27 https://onco-hema.healthbooktimes.org/article/127723-effect-of-acalabrutinib-in-combination-with-bendamustine-plus-rituximab-on-survival-endpoints-in-older-patients-with-mantle-cell-lymphoma-insights-fr 2025-06-16 https://onco-hema.healthbooktimes.org/article/125804-the-rapidly-evolving-treatment-landscape-in-newly-diagnosed-multiple-myeloma-current-status-and-future-directions 2025-06-16 https://onco-hema.healthbooktimes.org/article/92873-breaking-age-barriers-the-benefits-of-car-t-cell-therapies-in-treating-large-b-cell-lymphoma-in-older-patients 2025-06-16 https://onco-hema.healthbooktimes.org/article/127726-current-practice-in-urogenital-cancer-treatment 2025-05-27 https://onco-hema.healthbooktimes.org/article/73786-hematologic-updates-from-ash-2022 2025-05-27 https://onco-hema.healthbooktimes.org/article/73749-psma-directed-theragnostics-transforming-prostate-cancer-landscape 2025-06-16 https://onco-hema.healthbooktimes.org/article/90129-comprehensive-review-on-parp-inhibitors-in-ovarian-cancer-a-breakthrough-in-diagnostic-and-therapeutic-approaches 2025-05-27 https://onco-hema.healthbooktimes.org/article/30723-evolving-immuno-chemotherapeutic-paradigms-in-esophageal-and-gastric-cancers 2025-06-16 https://onco-hema.healthbooktimes.org/article/90103-evolving-therapeutic-strategies-in-gastrointestinal-stromal-tumors 2025-05-27 https://onco-hema.healthbooktimes.org/article/30737-the-evolving-systemic-treatment-for-advanced-hepatocellular-carcinoma 2025-06-16 https://onco-hema.healthbooktimes.org/article/91251-immune-checkpoint-inhibitors-in-endometrial-cancer-the-new-paradigm-of-treatment-for-advanced-and-recurrent-disease 2025-06-16 https://onco-hema.healthbooktimes.org/article/143604-forgiveness-in-oncology-a-legacy-of-saint-augustine 2025-12-18 https://onco-hema.healthbooktimes.org/article/120215-advancements-in-machine-learning-ml-transforming-the-future-of-blood-cancer-detection-and-outcome-prediction 2025-05-27 https://onco-hema.healthbooktimes.org/article/137802-tafasitamab-and-lenalidomide-as-second-line-treatment-in-an-elderly-patient-with-a-primary-refractory-double-hit-diffuse-large-b-cell-lymphoma 2025-08-05 https://onco-hema.healthbooktimes.org/article/126261-direct-oral-anticoagulants-in-cancer-patients 2025-06-16 https://onco-hema.healthbooktimes.org/article/154296-a-critical-approach-to-the-diagnostic-work-up-of-suspected-myelodysplastic-neoplasms-integrated-reports-technical-pitfalls-and-the-role-of-artificia 2026-01-05 https://onco-hema.healthbooktimes.org/article/154488-evolving-approaches-for-the-treatment-of-muscle-invasive-bladder-cancer 2026-01-05 https://onco-hema.healthbooktimes.org/article/154552-neurokinin-1-3-receptor-antagonists-for-vasomotor-symptoms-in-women-with-breast-cancer 2026-01-05 https://onco-hema.healthbooktimes.org/article/145932-shifting-paradigms-in-first-line-treatment-of-egfr-mutated-nsclc 2025-12-18 https://onco-hema.healthbooktimes.org/article/144748-hope-on-the-horizon-emerging-therapies-for-sclc 2025-12-18 https://onco-hema.healthbooktimes.org/article/147867-the-emerging-role-of-car-t-cell-immunotherapy-in-early-treatment-of-large-b-cell-lymphoma 2025-12-18 https://onco-hema.healthbooktimes.org/article/145888-who-benefits-most-patient-selection-frameworks-for-car-t-cell-therapy-in-non-hodgkin-lymphoma 2025-12-18 https://onco-hema.healthbooktimes.org/article/145278-treatment-options-for-hr-positive-her2-negative-advanced-breast-cancer-focus-on-capivasertib 2025-12-18 https://onco-hema.healthbooktimes.org/article/154294-recent-practice-changing-studies-in-the-first-line-treatment-of-advanced-and-metastatic-breast-cancer 2026-01-05 https://onco-hema.healthbooktimes.org/article/129504-immune-checkpoint-inhibitors-in-frail-older-patients-a-review-of-current-evidence 2025-05-27 https://onco-hema.healthbooktimes.org/article/133528-latest-advances-in-treatment-of-lymphoproliferative-disorders-key-highlights-from-ash-2024 2025-05-27 https://onco-hema.healthbooktimes.org/article/133534-immunotherapy-in-multiple-myeloma-recent-developments-in-monoclonal-antibodies-bispecifics-and-antibody-drug-conjugates 2025-05-27 https://onco-hema.healthbooktimes.org/article/133537-psma-targeting-radioligand-therapy-in-prostate-cancer 2025-05-27 https://onco-hema.healthbooktimes.org/article/133530-capivasertib-after-progression-on-cdk4-6-inhibitor-combined-with-endocrine-therapy-in-a-patient-with-hr-positive-her2-negative-metastatic-breast-canc 2025-05-27 https://onco-hema.healthbooktimes.org/article/133532-immunotherapy-and-tumor-heterogeneity-in-advanced-goblet-cell-adenocarcinoma-of-the-appendix-a-case-report 2025-05-27 https://onco-hema.healthbooktimes.org/article/133542-advances-in-breast-cancer-research-insights-from-sabcs-2024 2025-05-27 https://onco-hema.healthbooktimes.org/article/133544-advancements-in-the-treatment-of-high-risk-smoldering-myeloma-news-from-ash-2024 2025-05-27 https://onco-hema.healthbooktimes.org/issue/8591-vol-18-issue-4-2023 2023-12-22 https://onco-hema.healthbooktimes.org/issue/3555-vol-4-issue-2-2020 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3557-vol-6-issue-4-2020 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3552-vol-1-issue-1-2019 2021-10-05 https://onco-hema.healthbooktimes.org/issue/3553-vol-2-issue-2-2019 2021-10-05 https://onco-hema.healthbooktimes.org/issue/3556-vol-5-issue-3-2020 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3558-vol-7-issue-1-2021 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3559-vol-8-issue-2-2021 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3683-vol-9-issue-3-2021 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3939-vol-10-issue-4-2021 2022-03-21 https://onco-hema.healthbooktimes.org/issue/3554-vol-3-issue-1-2020 2022-03-21 https://onco-hema.healthbooktimes.org/issue/4248-vol-11-issue-1-2022 2022-04-06 https://onco-hema.healthbooktimes.org/issue/4538-vol-12-issue-2-2022 2022-07-14 https://onco-hema.healthbooktimes.org/issue/4681-vol-13-issue-3-2022 2023-01-18 https://onco-hema.healthbooktimes.org/issue/6763-vol-14-issue-4-2022 2023-01-25 https://onco-hema.healthbooktimes.org/issue/8477-vol-17-issue-3-2023 2023-12-22 https://onco-hema.healthbooktimes.org/issue/7181-vol-15-issue-1-2023 2023-04-18 https://onco-hema.healthbooktimes.org/issue/8140-vol-16-issue-2-2023 2023-07-17 https://onco-hema.healthbooktimes.org/issue/10317-vol-19-issue-1-2024 2024-04-25 https://onco-hema.healthbooktimes.org/issue/11293-vol-22-issue-4-2024 2025-01-17 https://onco-hema.healthbooktimes.org/issue/11292-vol-21-issue-3-2024 2025-01-17 https://onco-hema.healthbooktimes.org/issue/10760-vol-20-issue-2-2024 2024-07-16 https://onco-hema.healthbooktimes.org/issue/12278-vol-23-issue-1-2025 2025-05-14 https://onco-hema.healthbooktimes.org/issue/12621-vol-24-issue-2-2025 2025-07-07 https://onco-hema.healthbooktimes.org/issue/12996-vol-25-issue-3-2025 2025-12-18 https://onco-hema.healthbooktimes.org/issue/13636-vol-26-issue-4-2025 2026-01-05 https://onco-hema.healthbooktimes.org/section/2395-case-report 2021-10-13 https://onco-hema.healthbooktimes.org/section/2577-commentary 2024-07-12 https://onco-hema.healthbooktimes.org/section/2579-comments 2021-10-05 https://onco-hema.healthbooktimes.org/section/2628-congress-highlights 2021-10-22 https://onco-hema.healthbooktimes.org/section/4715-editorial 2024-10-07 https://onco-hema.healthbooktimes.org/section/2578-featured-article 2021-10-05 https://onco-hema.healthbooktimes.org/section/2627-mini-review 2021-10-22 https://onco-hema.healthbooktimes.org/section/3272-research-article 2022-11-15 https://onco-hema.healthbooktimes.org/section/2397-review 2021-10-13 https://onco-hema.healthbooktimes.org/section/2821-viewpoints 2022-03-14